List of Facet Biotech patents

List of Facet Biotech patents

List of ZeniMax Media patents

List of NGD Systems patents

List of Delta Systems, Inc. patents

List of SBIR/STTR awards granted to Applied Physical Sciences Corp (Aps)

List of companies in Coin98 Wallet's investment portfolio

Patents where

Current Assignee

Name

is

Facet Biotech

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7662384 Use of anti-α5β1 antibodies to inhibit cancer cell proliferation	Patent 7662384 was granted and assigned to Facet Biotech on February, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7662384	February 16, 2010
	‌ US Patent 7592004 Stable lyophilized pharmaceutical formulation of IgG antibodies	Patent 7592004 was granted and assigned to Facet Biotech on September, 2009 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7592004	September 22, 2009
	‌ US Patent 7709610 Therapeutic use of anti-CS1 antibodies	Patent 7709610 was granted and assigned to Facet Biotech on May, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7709610	May 4, 2010
	‌ US Patent 7732570 Alteration of Fc-fusion protein serum half-lives by mutagenesis	Patent 7732570 was granted and assigned to Facet Biotech on June, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7732570	June 8, 2010
	‌ US Patent 7807163 Antibodies against GPR64 and uses thereof	Patent 7807163 was granted and assigned to Facet Biotech on October, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7807163	October 5, 2010
	‌ US Patent 7732195 Tethered vectors for cell surface immunoglobulin display	Patent 7732195 was granted and assigned to Facet Biotech on June, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7732195	June 8, 2010
	‌ US Patent 7547544 Antibodies against GPR64 and uses thereof	Patent 7547544 was granted and assigned to Facet Biotech on June, 2009 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7547544	June 16, 2009
	‌ US Patent 7785816 Antibodies against cancer antigen TMEFF2 and uses thereof	Patent 7785816 was granted and assigned to Facet Biotech on August, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7785816	August 31, 2010
	‌ US Patent 7842293 Compositions and methods using anti-CS1 antibodies to treat multiple myeloma	Patent 7842293 was granted and assigned to Facet Biotech on November, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7842293	November 30, 2010
	‌ US Patent 7824678 Antibodies against cancer antigen TMEFF2 and uses thereof	Patent 7824678 was granted and assigned to Facet Biotech on November, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7824678	November 2, 2010
	‌ US Patent 7776585 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis	Patent 7776585 was granted and assigned to Facet Biotech on August, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7776585	August 17, 2010
	‌ US Patent 7914789 HEMCM42 antibodies	Patent 7914789 was granted and assigned to Facet Biotech on March, 2011 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7914789	March 29, 2011
	‌ US Patent 7674883 Antibodies against cancer antigen TMEFF2 and uses thereof	Patent 7674883 was granted and assigned to Facet Biotech on March, 2010 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	7674883	March 9, 2010
	‌ US Patent 8298530 Stable lyophilized pharmaceutical formulation of IgG antibodies	Patent 8298530 was granted and assigned to Facet Biotech on October, 2012 by the United States Patent and Trademark Office.		Facet Biotech		United States Patent and Trademark Office	8298530	October 30, 2012

14 results

0 selected

14 results

0 selected